• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非小细胞肺癌的诊断与分期

Diagnosing and staging of non-small cell lung cancer.

作者信息

Ferguson M K

机构信息

Department of Surgery, University of Chicago, Illinois.

出版信息

Hematol Oncol Clin North Am. 1990 Dec;4(6):1053-68.

PMID:1962775
Abstract

Lung cancer remains the most common cause of death due to neoplasm in the United States. Despite recent efforts, early diagnosis provided through screening studies has not resulted in improved survival. Most lung cancer victims are symptomatic at presentation, and 50% have distant metastases. The diagnosis, often suspected on plain chest radiograph, can usually be confirmed with bronchoscopy or sputum cytology. The most useful routine staging evaluation, in addition to history and physical examination, is computed tomography. The routine use of other staging modalities is not recommended. A new staging system, currently in use throughout North America, western Europe, and Japan, permits accurate estimation of prognosis and assignment to therapeutic groups.

摘要

在美国,肺癌仍是因肿瘤导致死亡的最常见原因。尽管最近做出了努力,但通过筛查研究实现的早期诊断并未带来生存率的提高。大多数肺癌患者在就诊时都有症状,50% 有远处转移。诊断通常在胸部X光平片上被怀疑,通常可以通过支气管镜检查或痰细胞学检查来确诊。除病史和体格检查外,最有用的常规分期评估是计算机断层扫描。不建议常规使用其他分期方式。一种新的分期系统目前在北美、西欧和日本普遍使用,它能够准确估计预后并分配到治疗组。

相似文献

1
Diagnosing and staging of non-small cell lung cancer.非小细胞肺癌的诊断与分期
Hematol Oncol Clin North Am. 1990 Dec;4(6):1053-68.
2
[Non-small cell lung cancer: evaluation of node and metastatic staging].[非小细胞肺癌:淋巴结及转移分期评估]
Rev Pneumol Clin. 2008 Oct;64(5):245-9. doi: 10.1016/j.pneumo.2008.07.011. Epub 2008 Oct 22.
3
Staging techniques for lung cancer.肺癌的分期技术
Chest Surg Clin N Am. 2000 Nov;10(4):781-801.
4
Investigation and staging of lung cancer.
Br J Hosp Med. 1996;55(10):627-30.
5
Lung cancer.肺癌
Radiol Clin North Am. 2007 Jan;45(1):21-43. doi: 10.1016/j.rcl.2006.10.004.
6
Transbronchial needle aspiration cytology of subcarinal lymph nodes for the staging procedure in the diagnosis of lung cancer.经支气管针吸活检术对隆突下淋巴结进行细胞学检查用于肺癌诊断中的分期程序。
Respirology. 2006 Nov;11(6):782-5. doi: 10.1111/j.1440-1843.2006.00928.x.
7
PET/CT for staging and monitoring non small cell lung cancer.正电子发射断层显像/计算机断层扫描用于非小细胞肺癌的分期和监测
Cancer Imaging. 2008 Oct 4;8 Spec No A(Spec Iss A):S27-31. doi: 10.1102/1470-7330.2008.9006.
8
Endoscopic ultrasound as a first test for diagnosis and staging of lung cancer: a prospective study.内镜超声作为肺癌诊断和分期的首选检查:一项前瞻性研究。
Am J Respir Crit Care Med. 2007 Feb 15;175(4):345-54. doi: 10.1164/rccm.200606-851OC. Epub 2006 Oct 26.
9
Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography.正电子发射断层扫描与计算机断层扫描相结合用于非小细胞肺癌分期
N Engl J Med. 2003 Jun 19;348(25):2500-7. doi: 10.1056/NEJMoa022136.
10
Staging non-small cell carcinoma of the lung using technetium-99m-labeled monoclonal antibodies.
Hematol Oncol Clin North Am. 1990 Dec;4(6):1069-78.

引用本文的文献

1
MicroRNA-497-5p inhibits proliferation and invasion of non-small cell lung cancer by regulating FGF2.微小RNA-497-5p通过调控成纤维细胞生长因子2抑制非小细胞肺癌的增殖和侵袭。
Oncol Lett. 2019 Mar;17(3):3425-3431. doi: 10.3892/ol.2019.9954. Epub 2019 Jan 21.
2
MicroRNA-20a promotes proliferation and invasion by directly targeting early growth response 2 in non-small cell lung carcinoma.微小RNA-20a通过直接靶向非小细胞肺癌中的早期生长反应因子2促进细胞增殖和侵袭。
Oncol Lett. 2018 Jan;15(1):271-277. doi: 10.3892/ol.2017.7299. Epub 2017 Oct 31.
3
Diagnosis of lung cancer by the analysis of exhaled breath with a colorimetric sensor array.
通过比色传感器阵列分析呼出气来诊断肺癌。
Thorax. 2007 Jul;62(7):565-8. doi: 10.1136/thx.2006.072892. Epub 2007 Feb 27.
4
Extended resection for higher-stage non-small-cell lung cancer.针对更高分期非小细胞肺癌的扩大切除术。
World J Surg. 1993 Nov-Dec;17(6):719-28. doi: 10.1007/BF01659081.